High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity

Documenti analoghi

• High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity
  di: King, Gwendalyn D., et al.
  Pubblicazione: (2008)
• Regulatable Gutless Adenovirus Vectors Sustain Inducible Transgene Expression in the Brain in the Presence of an Immune Response against Adenoviruses
  di: Xiong, Weidong, et al.
  Pubblicazione: (2006)
• A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics
  di: Puntel, Mariana, et al.
  Pubblicazione: (2010)
• Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial
  di: Ghulam Muhammad, A.K.M., et al.
  Pubblicazione: (2012)
• One-year Expression From High-capacity Adenoviral Vectors in the Brains of Animals With Pre-existing Anti-adenoviral Immunity: Clinical Implications
  di: Barcia, Carlos, et al.
  Pubblicazione: (2007)